title: Genome-wide association of an integrated osteoporosis-related phenotype: is there evidence for pleiotropic genes?
abstract: Multiple musculoskeletal traits assessed by various methods at different skeletal sites serve as surrogates for osteoporosis risk. However, it is a challenge to select the most relevant phenotypes for genetic study of fractures. Principal component analyses (PCA) were conducted in participants of the Framingham Osteoporosis Study on 17 measures including bond mineral density (BMD) (hip and spine), heel ultrasound, leg lean mass (LLM), and hip geometric indices, adjusting for covariates (age, height, body mass index [BMI]), in a combined sample of 1180 men and 1758 women, as well as in each sex. Four principal components (PCs) jointly explained ~69% of the total variability of musculoskeletal traits. PC1, explaining ~33% of the total variance, was referred to as the component of "Bone strength," because it included the hip and spine BMD as well as several hip cross-sectional properties. PC2 (20.5% variance) was labeled as "Femoral cross-sectional geometry;" PC3 (~8% variance) captured only ultrasound measures; PC4, explaining ~7% variance, was correlated with LLM and hip geometry. We then evaluated ~2.5 mil SNPs for association with PCs 1, 2, and 4. There were genome-wide significant associations (p < 5 × 10⁻⁸) between PC2 and HTR1E (that codes for one of the serotonin receptors) and PC4 with COL4A2 in women. In the sexes-combined sample, AKAP6 was associated with PC2 (p = 1.40 × 10⁻⁷). A single nucleotide polymorphism (SNP) in HTR1E was also associated with the risk of nonvertebral fractures in women (p = 0.005). Functions of top associated genes were enriched for the skeletal and muscular system development (p < 0.05). In conclusion, multivariate combination provides genetic associations not identified in the analysis of primary phenotypes. Genome-wide screening for the linear combinations of multiple osteoporosis-related phenotypes suggests that there are variants with potentially pleiotropic effects in established and novel pathways to be followed up to provide further evidence of their functions.
authors.affiliation: Hebrew SeniorLife Institute for Aging Research and Harvard Medical School, Boston, MA 02131, USA. karasik@hsl.harvard.edu
authors.forename: David
authors.initials: D
authors.lastname: Karasik
authors.forename: Ching Lung
authors.initials: CL
authors.lastname: Cheung
authors.forename: Yanhua
authors.initials: Y
authors.lastname: Zhou
authors.forename: L Adrienne
authors.initials: LA
authors.lastname: Cupples
authors.forename: Douglas P
authors.initials: DP
authors.lastname: Kiel
authors.forename: Serkalem
authors.initials: S
authors.lastname: Demissie
mesh_terms: D000368:Aged; D015331:Cohort Studies; D019295:Computational Biology; D005260:Female; D053263:Gene Regulatory Networks / Q000235:genetics; D058685:Genetic Pleiotropy / Q000235:genetics*; D055106:Genome-Wide Association Study; D006801:Humans; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000235:genetics*; D058866:Osteoporotic Fractures / Q000235:genetics; D010641:Phenotype; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D025341:Principal Component Analysis
references.citation: Osteoporos Int. 2006 Dec;17(12):1726-33
references.pmid: 16983459
references.citation: Nature. 1996 Dec 5;384(6608):458-60
references.pmid: 8945471
references.citation: BMJ. 1996 May 18;312(7041):1254-9
references.pmid: 8634613
references.citation: Osteoporos Int. 2002 Oct;13(10):796-802
references.pmid: 12378368
references.citation: Nature. 2005 Sep 22;437(7058):574-8
references.pmid: 16177794
references.citation: Arch Intern Med. 1979 Aug;139(8):857-61
references.pmid: 464698
references.citation: J Bone Miner Res. 2010 Mar;25(3):513-9
references.pmid: 20422623
references.citation: J Gerontol A Biol Sci Med Sci. 2010 Dec;65(12):1375-9
references.pmid: 20813793
references.citation: Bone. 2007 May;40(5):1378-88
references.pmid: 17320499
references.citation: J Bone Miner Res. 2010 Dec;25(12):2770-6
references.pmid: 20662074
references.citation: Osteoporos Int. 2006;17(4):593-9
references.pmid: 16447009
references.citation: BMC Genomics. 2008 Oct 31;9:516
references.pmid: 18976480
references.citation: Genet Epidemiol. 2008 Jan;32(1):9-19
references.pmid: 17922480
references.citation: Am J Hum Genet. 2010 Feb 12;86(2):229-39
references.pmid: 20096396
references.citation: Genome Biol. 2003;4(5):317
references.pmid: 12734004
references.citation: Ann Hum Genet. 1986 May;50(2):181-94
references.pmid: 3435047
references.citation: J Bone Miner Res. 2008 Dec;23(12):1892-904
references.pmid: 18684092
references.citation: Nat Genet. 2009 Nov;41(11):1199-206
references.pmid: 19801982
references.citation: J Bone Miner Res. 2007 Jun;22(6):808-16
references.pmid: 17352645
references.citation: J Bone Miner Res. 2002 Sep;17(9):1718-27
references.pmid: 12211443
references.citation: J Bone Miner Res. 2001 May;16(5):901-10
references.pmid: 11341335
references.citation: J Bone Miner Res. 2009 Apr;24(4):710-8
references.pmid: 19063671
references.citation: Neuroscience. 2008 Dec 2;157(3):683-96
references.pmid: 18926885
references.citation: J Bone Miner Res. 1998 Aug;13(8):1318-27
references.pmid: 9718201
references.citation: Am J Epidemiol. 2000 Apr 1;151(7):689-92
references.pmid: 10752796
references.citation: J Bone Miner Res. 2000 Apr;15(4):710-20
references.pmid: 10780863
references.citation: J Bone Miner Res. 2011 Apr;26(4):747-60
references.pmid: 20954177
references.citation: Endocr Rev. 2002 Jun;23(3):303-26
references.pmid: 12050122
references.citation: J Bone Miner Res. 2007 Feb;22(2):173-183
references.pmid: 17228994
references.citation: PLoS Genet. 2010 Jun 10;6(6):e1000977
references.pmid: 20548944
references.citation: Osteoporos Int. 1999;9(3):193-5
references.pmid: 10450405
references.citation: J Bone Miner Res. 2003 Oct;18(10):1758-65
references.pmid: 14584885
references.citation: Bone. 2004 Mar;34(3):547-56
references.pmid: 15003802
references.citation: Ann Hum Genet. 2002 Jan;66(Pt 1):61-74
references.pmid: 12015001
references.citation: Osteoporos Int. 2006;17(4):527-34
references.pmid: 16402164
references.citation: Cell. 2008 Nov 28;135(5):825-37
references.pmid: 19041748
references.citation: Am J Hum Biol. 2008 Nov-Dec;20(6):663-70
references.pmid: 18449921
references.citation: J Clin Endocrinol Metab. 2002 Jun;87(6):2460-6
references.pmid: 12050200
references.citation: Genes Dev. 2010 Oct 15;24(20):2330-42
references.pmid: 20952540
references.citation: Bone. 2007 Mar;40(3):743-50
references.pmid: 17079199
references.citation: Bone. 2007 Oct;41(4):722-32
references.pmid: 17662680
references.citation: Nat Genet. 2006 Aug;38(8):904-9
references.pmid: 16862161
references.citation: Nature. 2001 May 3;411(6833):41-2
references.pmid: 11333967
references.citation: J Bone Miner Res. 2011 Jun;26(6):1261-71
references.pmid: 21611967
references.citation: Bone. 2011 Mar 1;48(3):647-53
references.pmid: 20969983
references.citation: Bone. 2005 Jul;37(1):112-21
references.pmid: 15869917
references.citation: Cell. 2010 Jul 23;142(2):296-308
references.pmid: 20655470